Aliskiren

Aliskiren is the first drug that inhibits rennin, which has a key role in the regulation of blood pressure. It was approved by FDA for the treatment of hypertension in March 2007. For more information on Mode of action, Basis of discovery, Clinical data, Drug properties.
See: Nature Reviews, Vol 6, October 2007, 779.